PERAN FIBRINOGEN SEBAGAI FAKTOR PROGNOSTIK KARSINOMA HEPATOSELULAR
Abstract
Pendahuluan: Tulisan ini bertujuan untuk menentukan peran fibrinogen sebagai faktor prognostik pada pasien karsinoma hepatoselular.
Metode: Pencarian literatur secara terstruktur dilakukan dengan menggunakan PubMed, GoogleScholar, dan ScienceDirect sesuai dengan pertanyaan klinis yang dipilih. Pemilihan artikel dilakukan berdasarkan kriteria inklusi dan eksklusi. Tiga artikel yang terpilih kemudian dinilai kualitasnya dengan menggunakan kriteria yang mencakup validitas, importance, dan applicability.
Pembahasan: Ketiga penelitian yang digunakan pada artikel ini semua menyatakan bahwa kadar fibrinogen yang tinggi berhubungan dengan overall survival pada pasien karsinoma hepatoselular.
Simpulan: Kadar fibrinogen dapat menjadi faktor prognostik overall survival pada pasien karsinoma hepatoselular.
Downloads
Download data is not yet available.
References
1. Carr BI. tumors of the liver and biliary tree. In : Kasper DL, Hauser SL, Jameson JL, Fauci AS, Longo DL, Loscalzo J, editor. Harrison's principles of internal medicine. New York: McGraw Hill; 2011. 544-50.
2. Roberts LR. Liver and biliary tract tumors. In : Goldman L, Schafer AI, editor. GoldmanCecil medicine. Philadelphia: Saunders Elsevier; 2016. 1481-93.
3. Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy. Neoplasia. 2002 Nov; 4(6): 465-473.
4. Collen D, Tytgat GN, Claeys H, Piessens R. Metabolism and distribution of fibrinogen. Br J Haematol. 1972; 22: 681-700.
5. Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma. Oncology. 2013 November; 85: 269-277.
6. Jiang HG, Li J, Shi SB, Chen P, Ge LP, Jiang Q, Tang XP. Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer. Med Oncol. 2014 July; 31(7).
7. Wen J, Yang Y, Ye F, Huang X, Li S, Wang Q, Xie X. The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment. Breast. 2015 Dec; 24(6).
8. Yu X, Hu F, Yao Q, Li C, Zhang H, Xue Y. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer. 2016 July; 16.
9. Li H, Zhao T, Ji X, Liang S, Wang Z, Yang Y, Yin J, Wang R. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer. Tumour Biol. 2016 Mar; 27(3).
10. Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: a comprehensive review. World Journal of Hepatology. 2015 November; 7(26): 2648-63.
11. Byam J, Renz J, Millis JM. Liver transplantation for hepatocellular carcinoma. Hepatobiliary Surgery and Nutrition. 2013 February; 2(1): 22-30.
12. Greten TF, Papendorf F, Bleck JS, Kirchoff T. Survival rate in patients with hepatocellular carcinoma. British Journal of Cancer. 2005 May; 92(10): 1862-8.
13. Liu Z, Guo H, Gao F, Shan Q, Li J, Xie H, et al. Fibrinogen and D-dimer levels elevate in advanced hepatocellular carcinoma: High pretreatment fibrinogen levels predict poor outcomes. Hepatology Research. 2017; 2017.
14. Zhang X, Long Q. Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients. Medicine. 2017 March; 96(17).
15. Sheng L, Luo M, Sun X, Lin N, Mau W, Su D. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. International Journal of Cancer. 2017; 133(2013): 2720-2725Sahni A, Simpson-Haidaris PJ
16. Sahni SK, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor2 (FGF-2). J Thromb Haemost 2008; 6: 176-83.
17. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000; 96: 3772-3778
18. Zheng S, Shen J, Jiao Y, et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci 2009; 100: 859-65.
2. Roberts LR. Liver and biliary tract tumors. In : Goldman L, Schafer AI, editor. GoldmanCecil medicine. Philadelphia: Saunders Elsevier; 2016. 1481-93.
3. Caine GJ, Stonelake PS, Lip GY, Kehoe ST. The hypercoagulable state of malignancy. Neoplasia. 2002 Nov; 4(6): 465-473.
4. Collen D, Tytgat GN, Claeys H, Piessens R. Metabolism and distribution of fibrinogen. Br J Haematol. 1972; 22: 681-700.
5. Kinoshita A, Onoda H, Imai N, Iwaku A, Oishi M, Tanaka K, et al. Elevated plasma fibrinogen levels are associated with a poor prognosis in patients with hepatocellular carcinoma. Oncology. 2013 November; 85: 269-277.
6. Jiang HG, Li J, Shi SB, Chen P, Ge LP, Jiang Q, Tang XP. Value of fibrinogen and D-dimer in predicting recurrence and metastasis after radical surgery for non-small cell lung cancer. Med Oncol. 2014 July; 31(7).
7. Wen J, Yang Y, Ye F, Huang X, Li S, Wang Q, Xie X. The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment. Breast. 2015 Dec; 24(6).
8. Yu X, Hu F, Yao Q, Li C, Zhang H, Xue Y. Serum fibrinogen levels are positively correlated with advanced tumor stage and poor survival in patients with gastric cancer undergoing gastrectomy: a large cohort retrospective study. BMC Cancer. 2016 July; 16.
9. Li H, Zhao T, Ji X, Liang S, Wang Z, Yang Y, Yin J, Wang R. Hyperfibrinogenemia predicts poor prognosis in patients with advanced biliary tract cancer. Tumour Biol. 2016 Mar; 27(3).
10. Waller LP, Deshpande V, Pyrsopoulos N. Hepatocellular carcinoma: a comprehensive review. World Journal of Hepatology. 2015 November; 7(26): 2648-63.
11. Byam J, Renz J, Millis JM. Liver transplantation for hepatocellular carcinoma. Hepatobiliary Surgery and Nutrition. 2013 February; 2(1): 22-30.
12. Greten TF, Papendorf F, Bleck JS, Kirchoff T. Survival rate in patients with hepatocellular carcinoma. British Journal of Cancer. 2005 May; 92(10): 1862-8.
13. Liu Z, Guo H, Gao F, Shan Q, Li J, Xie H, et al. Fibrinogen and D-dimer levels elevate in advanced hepatocellular carcinoma: High pretreatment fibrinogen levels predict poor outcomes. Hepatology Research. 2017; 2017.
14. Zhang X, Long Q. Elevated serum plasma fibrinogen is associated with advanced tumor stage and poor survival in hepatocellular carcinoma patients. Medicine. 2017 March; 96(17).
15. Sheng L, Luo M, Sun X, Lin N, Mau W, Su D. Serum fibrinogen is an independent prognostic factor in operable nonsmall cell lung cancer. International Journal of Cancer. 2017; 133(2013): 2720-2725Sahni A, Simpson-Haidaris PJ
16. Sahni SK, et al. Fibrinogen synthesized by cancer cells augments the proliferative effect of fibroblast growth factor2 (FGF-2). J Thromb Haemost 2008; 6: 176-83.
17. Sahni A, Francis CW. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. Blood 2000; 96: 3772-3778
18. Zheng S, Shen J, Jiao Y, et al. Platelets and fibrinogen facilitate each other in protecting tumor cells from natural killer cytotoxicity. Cancer Sci 2009; 100: 859-65.
Published
2018-08-30
How to Cite
DEWANTORO, Gadang R.; HIDAYAT, Rudy.
PERAN FIBRINOGEN SEBAGAI FAKTOR PROGNOSTIK KARSINOMA HEPATOSELULAR.
Essential: Essence of Scientific Medical Journal, [S.l.], v. 16, n. 1, p. 10-20, aug. 2018.
ISSN 2655-6472.
Available at: <https://ojs.unud.ac.id/index.php/essential/article/view/44561>. Date accessed: 04 nov. 2024.
Section
Artikel Tinjauan Pustaka
SUBMISSION
